TABLE 3.
First author, year [ref.] | Type of study | Sample | Bacterial detection method |
COPD patients
ICS/no ICS |
Key findings | ||
Bacterial load | Species change | Diversity | |||||
Garcha, 2012 [ 132 ] | Cohort | Sputum | qPCR | 47/5 | ↑ | = | X |
Wang, 2019 [ 124 ] | Cohort | Sputum | 16S rRNA+qPCR | 25/7 | = | ↑ H. influenzae ↑ M. catarrhalis |
↓ |
Ramsheh, 2021 [ 126 ] | Cohort | Bronchial brush | 16S rRNA | 192/147 | = | = | ↓ |
Beech, 2020 [ 125 ] | Cohort | Sputum | qPCR | 199/37 | = | = | X |
Beech, 2021 [ 46 ] | Cohort | Sputum | qPCR | 43/17 | = | = | X |
Singanayagam, 2019 [ 134 ] | Cohort | Sputum | 16S rRNA | 10/13 | ↑ | ↑ S. pneumoniae | X |
Contoli, 2017 [ 98 ] | RCT | Sputum | qPCR | 30/30 | ↑ | ↑ H. influenzae# ↑ S. pneumoniae# |
↑ |
Leitao Filho, 2021 [ 135 ] | RCT | Bronchial brush | 16S rRNA | 18 FP/20 | = | ↓ Haemophilus ↑ Firmicutes |
↓ |
18 BD/20 | = | = | = |
=: no change; ↑: increase; ↓: decrease; X: not measured. qPCR: quantitative PCR; 16S rRNA: 16S ribosomal RNA gene sequencing; H. influenzae: Haemophilus influenzae; M. catarrhalis: Moraxella catarrhalis; S. pneumoniae: Streptococcus pneumoniae; RCT: randomised controlled trial; FP: fluticasone propionate; BD: budesonide. #: in eosinophil-low patients.